NMRA 144 DEF-14A Report Nov. 12, 2025 | Alphaminr
Neumora Therapeutics, Inc.

NMRA 144 Report ended Nov. 12, 2025

CIK: 1885522
Filing Type: 144
Report Date: 2025-11-12
Download URL: https://www.sec.gov/Archives/edgar/data/1885522/000162828025051788/xsl144X01/primary_doc.xml
]]>
TABLE OF CONTENTS